HIGHLIGHTS
- who: Xinghai Zhang from the (UNIVERSITY) have published the research: A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery, in the Journal: (JOURNAL) of 19/06/2022
- what: The experiments were performed similarly to the procedure described for animals challenged by the Delta variant but with a 3-fold higher antibody dose and without the 2-dose 58G6 group Signal Transduction and Targeted Therapy 7:301 Signal Transduction and Targeted Therapy 7:301 (Fig 4a).
- how: The authors conducted an in_vivo study with hamsters. All . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.